Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
RecruitingNCT06473623Phase: NAStarted 2025-12-01
Summary
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
Eligibility
Sex
ALL
Min Age
7 Years
Max Age
26 Years
Locations
Hong Kong Science ParkTai Po, Hong Kong
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06473623